[Dicarbamine as a hemoprotective agent in patients with hemoblastoses treated with chemotherapy].
O V
OV
Ivanova
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D002208:Caproates; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007970:Leukopenia / Q000139:chemically induced / Q000517:prevention & control; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control; D020011:Protective Agents / Q000627:therapeutic use*; D016896:Treatment Outcome
D002208:Caproates; D007093:Imidazoles; D020011:Protective Agents; C539419:pentanedioic acid imidazolyl ethanamide